Morning Overview on MSN
New combination therapy achieves unprecedented remission in glioblastoma brain cancer models
Glioblastoma is the most aggressive primary brain cancer in adults, killing most patients within two years of diagnosis ...
Mortality disparities among people of different genetic ancestries are increasing, highlighting the need for more diverse ...
At AACR 2026, scientists showcased advances in radiotherapeutics, antibody-drug conjugates, T cell engagers, and ...
Lung cancer remains the leading cause of cancer-related mortality worldwide, underscoring the urgent need for improved therapeutic strategies grounded in ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Earlier computational models helped scientists categorize ...
Researchers at VIB and VUB have developed a powerful new way to study how the immune system behaves inside lung tumors. By combining a patient-relevant mouse model with single-cell technologies, the ...
Morning Overview on MSN
Study links extra chromosome sets to tumor spread and cell mobility
Cancer cells that accumulate extra copies of their entire chromosome set can start behaving like immune cells, swallowing ...
With more accessible AI models shifting the landscape of cancer research and treatments, scientists weigh in on whether AI ...
9don MSN
Turning immune cells into tumor allies: A cancer cell protein can reprogram frontline defenders
Cancer cells can disarm the immune system not just by hiding from it, but by actively reprogramming nearby immune cells into a suppressed state. This previously unrecognized molecular interaction, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results